Page 195 - Active Full Array Local Dimming News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Active full array local dimming. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Active Full Array Local Dimming Today - Breaking & Trending Today

"A K-Seat-Based PID Controller for Active Seat Suspension to Enhance Mo" by Georgios Papaioannou, Donghong Ning et al.

Autonomous vehicles (AVs) are expected to have a great impact on mobility by decreasing commute time and vehicle fuel consumption and increasing safety significantly. However, there are still issues that can jeopardize their wide impact and their acceptance by the public. One of the main limitations is motion sickness (MS). Hence, the last year's research is focusing on improving motion comfort within AVs. On one hand, users are expected to perceive AVs driving style as more aggressive, as it might result in excessive head and body motion. Therefore, speed reduction should be considered as a countermeasure of MS mitigation. On the other hand, the excessive reduction of speed can have a negative impact on traffic. At the same time, the user's dissatisfaction, i.e., acceptance and subjective comfort, will increase due to a longer journey time. Therefore, additional approaches to mitigating MS should be considered without affecting journey time, such as vehicle and seat suspensi ....

Automated Vehicles , Tk Seat , Motion Sickness , Ride Comfort , Seat Design ,

Active Biotech: FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration (FDA) has granted tasquinimod Orphan Drug Designation for the treatment of myelofibrosis. "The ....

Hans Kolam , Loncode Institute , Erasmus University Medical Center , Drug Administration , Lund May , Nasdaq Stockholm , Orphan Drug Designation , Drug Designation , Active Biotech ,